INTERCHANGEABLE TERMS: "DO NOT MIX DRUGS" SUGGESTED BY FDA
This article was originally published in The Tan Sheet
Executive Summary
INTERCHANGEABLE TERMS: "DO NOT MIX DRUGS" SUGGESTED BY FDA as a possible substitute in OTC drug labeling for the term "Drug interaction precaution" in a proposed rule published in the Aug. 3 Federal Register. The agency also is proposing the term "Avoid mixing drugs" as another alternative.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning